SCHEDULE: BlackRock Boosts Viatris Stake to 6.6%
Beneficial Ownership Report
BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, reporting beneficial ownership of 6.6% of Viatris Inc.'s common stock as of September 30, 2025.
Summary
- BlackRock, Inc. beneficially owns 76,382,158 shares of Viatris Inc. common stock.
- This ownership represents 6.6% of the total outstanding common stock of Viatris Inc.
- BlackRock holds sole voting power over 71,733,857 shares.
- BlackRock holds sole dispositive power over 76,382,158 shares.
- The securities were acquired and are held in the ordinary course of business.
- The acquisition was not for the purpose of or with the effect of changing or influencing the control of Viatris Inc.
Sentiment
Score: 7
Explanation: The filing indicates a significant, passive institutional investment by BlackRock, which is generally viewed positively as it signals confidence from a major asset manager. However, it does not contain operational or financial performance data for Viatris Inc. to warrant a higher score.
Positives
- Increased transparency regarding significant institutional ownership in Viatris Inc.
- BlackRock's certification that its stake is for investment purposes in the ordinary course of business, not for control, which may reduce concerns about potential hostile takeover attempts.
Future Outlook
This filing does not provide any forward-looking statements or guidance regarding Viatris Inc.'s future performance or strategic direction.
Management Comments
- "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."
Industry Context
BlackRock, Inc. is one of the world's largest asset managers, and its significant stake in Viatris Inc., a global pharmaceutical company, reflects its role as a major institutional investor in the healthcare sector. Such filings provide transparency into large passive investment positions.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Attorney-in-fact (for BlackRock, Inc.) | Previous list of attorneys-in-fact (from April 30, 2023 Power of Attorney) | Eric Andruczyk, Richard Cundiff, R. Andrew Dickson, III, Spencer Fleming, Laura Hildner, David Maryles, Christopher Meade, Charles Park, James Raby, Daniel Riemer, David Rothenberg and Brenda Schulz | 2025-01-21 | Updated and re-executed Power of Attorney, expressly revoking the prior one dated April 30, 2023. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Update (for BlackRock, Inc.) | BlackRock, Inc. updated its Power of Attorney, appointing a new list of individuals to execute documents related to ownership or control-person reporting requirements. This document expressly revokes the prior Power of Attorney dated April 30, 2023. | 2025-01-21 | Streamlines BlackRock's internal compliance and reporting processes for SEC and other regulatory filings. This change pertains to BlackRock's internal governance, not Viatris Inc.'s. |
Stakeholder Impact
- Shareholders of Viatris Inc. gain transparency into the significant institutional ownership structure of the company.
- The market may view a substantial, passive stake by a major asset manager like BlackRock as a sign of long-term investment interest.
Next Steps
- BlackRock, Inc. will continue to file amendments to its Schedule 13G as required by SEC regulations if its beneficial ownership percentage changes significantly or if its investment intent shifts.
Key Dates
| Date | Description |
|---|---|
| 2025-01-21 | Execution date of the Power of Attorney by BlackRock, Inc. |
| 2025-09-30 | Date of event which requires filing of this statement (ownership snapshot date). |
| 2025-10-17 | Date of filing/signature of the Schedule 13G Amendment No. 4. |
Keywords
BlackRock, Viatris, Schedule 13G, Institutional Ownership, Common Stock, Pharmaceutical, Healthcare, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.